Skip to main content
logo
Onco-Innovations Limited (NEO:ONCO)
Canada flag Canada · Delayed Price · Currency is CAD
0.5700
-0.0200 (-3.39%)
Aug 19, 2026, 3:55 PM EST

Onco-Innovations Cash Flow Statement

Millions CAD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Net Income
-10.78-7.56-0.39-0
Asset Writedown & Restructuring Costs
-2.76--
Stock-Based Compensation
4.431.7--
Other Operating Activities
-0.16--
Change in Accounts Receivable
0.04-0.05--
Change in Accounts Payable
0.440.130.390
Change in Other Net Operating Assets
0.6-1--
Operating Cash Flow
-5.27-3.87-0.01-0
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Cash Acquisitions
-0.1--
Investing Cash Flow
-0.1--

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Long-Term Debt Repaid
--0.01--
Net Debt Issued (Repaid)
--0.01--
Issuance of Common Stock
5.074.561.350.02
Other Financing Activities
-0.14-0.12--
Financing Cash Flow
4.934.431.350.02

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Net Cash Flow
-0.340.661.340.02

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Levered Free Cash Flow
0.8-1.26--
Unlevered Free Cash Flow
0.8-1.26--

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Change in Working Capital
1.08-0.920.390